NCT06942533Recruiting
Effect of Visual Feedback From the SpiroGym Mobile Application
The Effect of Visual Feedback From the SpiroGym Mobile Application on Expiratory Muscle Strength Training Performance in Patients With Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 1 Dec 2025
Brief summary (registry, in English)
The previous pilot study showed that two weeks of intensive expiratory muscle strength training (EMST) with SpiroGym was sufficient to significantly improve voluntary peak cough flow (PCF). The improvement was quantitatively comparable to that reported in other intensive EMST studies of longer duration. To explain this rapid improvement, we considered the potential contribution of SpiroGym's visual feedback. We assumed that real-time visual feedback increased training effort compared with conventional EMST performed without immediate feedback. The aim of this study is to evaluate the effect of visual feedback provided by the SpiroGym mobile application on performance during expiratory muscle strength training in patients with Parkinson's disease.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 9 Apr 2025
- Start date
- 1 May 2025
- Primary completion date
- 1 May 2026
- Lead sponsor
- General University Hospital, Prague
- Diseases
- Parkinson disease
- NCT number
- NCT06942533
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 1 May 2025 to the primary completion date, 1 May 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- History of head or neck cancer or previous surgical interventions in the neck region.
Other illness
- Other neurological disorders
- Significant cognitive impairment
- Major psychiatric disorder
- Illness during the study period
Who the study is looking for
- Diagnosis of Parkinsons disease
- Stable dopaminergic medication (stable dose for at least 1 month)
Age in the registry: 40 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Neurology and Centre of Clinical Neuroscience First Faculty of Medicine, Charles University and General University Hospital in Prague Coordinator of this site? Confirm its status | Prague | Czechia | Recruiting |
| General University Hospital Coordinator of this site? Confirm its status | Prague | Czechia | Recruiting |
Related publications
- Visual feedback increases expiratory muscle training effort in Parkinson's disease: a randomised crossover trial.J Neuroeng Rehabil · 2026 · PMID 42881452
This page is information, not medical advice. Discuss any trial with your doctor.